BerGenBio ASA (BRRGF) has released an update.
BerGenBio ASA successfully conducted an extraordinary general meeting virtually on October 10, 2024, where all proposed resolutions were passed as outlined in their previous notice. The details of the resolutions are documented in the meeting minutes, which are accessible on the company’s website. Stakeholders can contact CEO Martin Olin or CFO Rune Skeie for more information.
For further insights into BRRGF stock, check out TipRanks’ Stock Analysis page.
